This UROwebinar tackles a central uro-oncology debate: “Do we need TURBT in MIBC?” As advancements in MRI for bladder cancer challenge traditional methods, this session features key opinion leaders presenting opposing views on whether a full TURBT can be replaced by a simple biopsy for bladder cancer staging. The discussion explores the pros and cons of this approach and presents key arguments for maintaining TURBT as a foundational procedure for treating muscle-invasive bladder cancer. This webinar offers critical insights into the future of TURBT and its role in modern bladder cancer treatment protocols.
This recording is the second part of the successful series “Everything you always wanted to know about TURBT but were afraid to ask”.
Speakers:
- Prof. P. Gontero (IT)
- Prof. Dr. P. Mariappan (GB)
- Prof. N. James (GB)
- Prof. A. Masson-Lecomte (FR)
- Prof. M. Rouprêt (FR)
